Patent · US Active

Imidazo[1,2-A]pyrimidines as orexin receptor antagonists

US8093255B2 · kind B2 · utility

8Cited by
0References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 9, 2009
Grant dateJan 10, 2012
Priority date—
Expiry dateMay 21, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to imidazopyrimidine substituted piperidine derivatives and their use as pharmaceuticals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.